Our fellows are expected to engage in scholarly activity as an integral part of their fellowship training. There are over 120 medical oncologists and hematologists in Kaiser Permanente Northern California, many of whom are actively engaged in clinical research and conduction of over 50 NCI clinical trials at any one time. There are many opportunities to work with our physicians to conduct meaningful clinical research.
Our San Francisco Medical Center GME office has a dedicated research program manager who provides support to residents and fellows’ research endeavors. Her role is to assist trainees at each phase of the project, ranging from the development of a research idea and proposal, study design, statistical techniques, conducting of the project, analysis of results and preparation of manuscripts for publication.
Research phase fellow salaries will be fully supported by the program. However, all fellows are strongly encouraged to apply for research grant funding or other training grants.
Kaiser Permanente Oncology Clinical Trials (KPOCT) Program
The KPOCT program is a nationally recognized cancer clinical trials program that enables many oncology patients in the Northern California region to benefit from clinical trials and research studies. KPOCT is a key member in the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). Nationwide, Kaiser Permanente enrolls one of every 40 patients participating in cancer clinical trials. At any one time, there are over 50 cancer trials open to enrollment. KPOCT has become one of the national leaders in the NCI clinical trial program, enrolling between 400-500 patients into these trials every year. All members of the oncology faculty in the program are NCI registered clinical trial investigators.
In 2014 the NCI awarded the KPOCT program $10.4 million over five years. The funding will enable the program to further develop the clinical trials program infrastructure within KPOCT, and to expand research into cancer care delivery, specifically on evaluating alternative treatment delivery systems, examining disease prevention, exploring pain and symptom management, and investigating disparities in cancer outcomes and how to alleviate them.
Oncology/hematology fellows will be able to develop scholarly projects as part of KPOCT. There will be opportunities to review and participate in clinical trial protocol development. An anticipated strength of the program is the unique opportunities offered by the NCORP for fellows to develop scholarly projects in evaluation of delivery systems, cost comparisons, cost analysis, efficiency and outcome disparities, and their effects on cancer patient care.
KP Division of Research (DOR)
The Kaiser DOR conducts epidemiological, translational and health services research, as well as clinical trials. It has over 250 ongoing studies supported by more than $100 million funding per year. Sources of funding include the National Institute of Health, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. The DOR consists of over 600 people, including over 60 investigators. It is located in Oakland and is an integral part of The Permanente Medical Group. Within the DOR, a group of more than 10 investigators participate in cancer-related research. The cancer section is headed by Dr. Laurel Habel.
Fellows will have ample opportunity to be mentored by investigators in the DOR. For those fellows with interest in epidemiology, outcomes, and service delivery research, the DOR offers incredible opportunities for education, collaboration and building a career in those areas. Fellows will work closely with investigators in developing relevant research questions, build necessary research methodology and skills, develop the research plan, conduct the research, analyze data, and summarize the results and publish in peer-reviewed journals.
Future opportunities under development
Delivery Science Fellowship and Research
Combined program – Fellowship and Berkeley MPH